COVID-19
COVID-19 is a respiratory illness caused by the SARS-CoV-2 virus. It spread rapidly around the world in 2020, leading to a global pandemic.
Common symptoms of COVID-19 include: Fever, Cough, Shortness of breath, Fatigue, Muscle or body aches, Headache, Loss of taste or smell, Sore throat, Congestion or runny nose, Nausea or vomiting and Diarrhea.
Our digital patient recruitment platform can help you find participants for your COVID-19 and other clinical trials. Even though the pandemic is easing in some places, the ongoing threat of new variants and the emergence of long COVID necessitate continued research. We have a proven track record in recruiting patients for a variety of clinical trials worldwide and can assist you in finding the right participants for your study.
THE COVID-19 DISRUPTION
The COVID-19 pandemic severely disrupted non-COVID-19 clinical trials, with many studies halted or delayed due to patient reluctance to visit research sites and resource allocation shifts to critical care.
To better understand these challenges, we offer valuable patient insights from our global surveys across various therapeutic areas. Our company has maintained full operations worldwide, with on-the-ground teams supporting clinical trials in over 50 countries. We can help you overcome pandemic-related obstacles and successfully conduct your critical research.
Recruitment approach
Our targeted recruitment approach identifies and engages ideal participants for your COVID-19 trials.
We use a combination of demographic, geographic, interest-based, and database information to find patients who match your specific criteria. By pinpointing the right people, we increase enrollment rates and reduce participant dropout. Our global reach and extensive database of potential participants further enhance our recruitment capabilities.
We are dedicated to facilitating groundbreaking discoveries, improving patient outcomes, and advancing clinical research solutions.
